Ventricular Arrhythmia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia
Condition: Ventricular Outflow Tract TachycardiaIntervention: Procedure: Radio-frequency AblationSponsor: St. Jude MedicalEnrolling by invitation - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2016 Category: Research Source Type: clinical trials
EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia
Condition: Ventricular Outflow Tract TachycardiaIntervention: Procedure: Radio-frequency AblationSponsor: St. Jude MedicalNot yet recruiting - verified March 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2016 Category: Research Source Type: clinical trials
Non-invasive programmed stimulation to identify high-risk patients with implanted cardioverter defibrillator (the NIPS-ICD study): study protocol for a randomized controlled trial
Discussion
It is expected that appropriate ICD interventions during follow-up will occur more often in patients who had sustained ventricular arrhythmias induced during NIPS.
Clinical trials registry
ClinicalTrials.gov, NCT02373306, date of registration: 26 February 2015. (Source: Trials)
Source: Trials - January 27, 2016 Category: Research Source Type: clinical trials
Upstream therapeutic strategies of Valsartan and Fluvastatin on Hypertensive patients with non-permanent Atrial Fibrillation (VF-HT-AF): study protocol for a randomized controlled trial
This study was designed to examine whether valsartan or fluvastatin can reduce the risk of non-permanent AF in patients with hypertension.
Methods/design
The VF-HT-AF study is a multicenter, randomized, open-label, four-arm parallel group study with comparative evaluation of valsartan and fluvastatin as upstream therapies for the treatment of non-permanent AF complicated by hypertension. The primary outcome measure is change in the development of paroxysmal AF into persistent or permanent AF, the development of persistent AF to permanent ...
Source: Trials - August 7, 2015 Category: Research Source Type: clinical trials
Assessment of Ventricular Arrhythmia Risk After CRT-D Replacement for Patients With Primary Prevention Indication
Conditions: Cardiac Resynchronization; Biventricular Pacemakers, Artificial; Cardioverter-Defibrillators, Implantable; Device ReplacementIntervention: Device: CRT-D device replacementSponsor: Biotronik SE & Co. KGNot yet recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2014 Category: Research Source Type: clinical trials
Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator
Condition: Ventricular ArrhythmiaInterventions: Drug: GS-6615; Drug: Placebo to match GS-6615Sponsor: Gilead SciencesRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2014 Category: Research Source Type: clinical trials
